Clinical and Research Expertise
The TMS program at the University of Pennsylvania is one of the leading TMS providers in the US with more than 10,000 TMS sessions administered over the last 10 years.
The University of Pennsylvania TMS service was involved with the largest study of TMS as a treatment for major depression. That large, multicenter study showed that TMS is a well-tolerated and effective treatment option for patients with depression and was pivotal for its subsequent FDA approval. Data on the effectiveness and safety of TMS provided at our clinical center after FDA approval has been published in academic peer reviewed journals.
Back to Top